Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy

A. Harrer*, H. Tumani, S. Niendorf, F. Lauda, C. Geis, A. Weishaupt, C. Kleinschnitz, S. Rauer, J. Kuhle, M. Stangel, F. Weber, M. Uhr, M. Linnebank, B. Wildemann, S. Jarius, M. Guger, I. Ayzenberg, A. Chan, U. Zettl, H. WiendlG. Pilz, W. Hitzl, J. R. Weber, J. Kraus

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1209-1212
JournalMultiple Sclerosis Journal
Volume19
Issue number9
DOIs
Publication statusPublished - Aug 2013

Keywords

  • Natalizumab
  • multiple sclerosis
  • oligoclonal bands
  • intrathecal IgG
  • cerebrospinal fluid

Cite this